You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys Troponin I IVD Elecsys® Troponin I CPS_000526 05094810160 Troponin I Elecsys cobas e 100 Elecsys Troponin I 04015630939374 Reagents, kits 100 tests cobas e 601/602 true 07028059190 Troponin I Elecsys E2G 300 Elecsys Troponin I 04015630940325 Reagents, kits 300 tests cobas e 402/801 true 05094810190 Troponin I Elecsys cobas e 100 Elecsys Troponin I 04015630924332 Reagents, kits 100 tests cobas e 601/602 true 05094810501 Elecsys Troponin I en 11 FF0000000646E50E FF000000000DDE0E 05094810160 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis of myocardial infarction.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07028059500 Elecsys Troponin I en 3 FF00000003EDF00E FF000000019DC10E 07028059190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis and treatment of myocardial infarction and cardiac muscle damage.Cardiac troponin I determinations aid in the risk stratification of patients with unstable angina pectoris or non‑ST‑segment elevation acute coronary syndrome with respect to relative risk of mortality, myocardial infarction, or increased probability of ischemic events requiring urgent revascularization procedures.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07028059500 Elecsys Troponin I en 7 FF000000069D110E FF0000000435400E 07028059190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis and treatment of myocardial infarction and cardiac muscle damage.Cardiac troponin I determinations aid in the risk stratification of patients with unstable angina pectoris or non‑ST‑segment elevation acute coronary syndrome with respect to relative risk of mortality, myocardial infarction, or increased probability of ischemic events requiring urgent revascularization procedures.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 05094810500 Elecsys Troponin I en 11 FF00000004A1C90E FF000000000ADA0E 05094810190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis and treatment of myocardial infarction and cardiac muscle damage.Cardiac troponin I determinations aid in the risk stratification of patients with unstable angina pectoris or non‑ST‑segment elevation acute coronary syndrome with respect to relative risk of mortality, myocardial infarction, or increased probability of ischemic events requiring urgent revascularization procedures.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en